NEW YORK, Nov. 18, 2016 /PRNewswire/ -- The Law Offices of
Vincent Wong announce that a class
action lawsuit has been commenced in the USDC for the District of
Nevada on behalf of investors who
purchased Spectrum Pharmaceuticals, Inc. (NASDAQGS: SPPI)
securities between February 28, 2013
and September 16, 2016.
Click here to learn about the case:
http://www.wongesq.com/pslra/spectrum-pharmaceuticals-inc.
There is no cost or obligation to you.
According to the complaint, throughout the Class Period
defendants made false and/or misleading statements and/or failed to
disclose that: (1) the Food and Drug Administration (the "FDA")
questioned whether the data from the 611 and 612 Studies were
clinically significant; (2) the FDA informed defendants in
December 2012 not to submit the New
Drug Application based on data from the 611 and 612 Studies; and
(3) accordingly, defendants' public statements concerning the
Company's business, operations and prospects were materially false
and misleading at all relevant times.
If you suffered a loss in Spectrum Pharmaceuticals you have
until November 21, 2016 to request
that the Court appoint you as lead plaintiff. Your ability to share
in any recovery doesn't require that you serve as a lead plaintiff.
To obtain additional information, contact Vincent Wong, Esq. either via email
vw@wongesq.com, by telephone at 212.425.1140, or visit
http://www.wongesq.com/pslra/spectrum-pharmaceuticals-inc.
Vincent Wong, Esq. is an
experienced attorney that has represented investors in securities
litigations involving financial fraud and violations of shareholder
rights. Attorney advertising. Prior results do not guarantee
similar outcomes.
CONTACT:
Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
Fax. 866.699.3880
E-Mail: vw@wongesq.com
Logo - http://photos.prnewswire.com/prnh/20140904/143045
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/sppi-upcoming-deadline-the-law-offices-of-vincent-wong-reminds-shareholders-of-a-class-action-involving-spectrum-pharmaceuticals-inc-and-a-lead-plaintiff-deadline-of-november-21-2016-300365919.html
SOURCE The Law Offices of Vincent
Wong